What is the price target for PLNT stock?
24 analysts have analysed PLNT and the average price target is 132.48 USD. This implies a price increase of 79.51% is expected in the next year compared to the current price of 73.8.
NYSE:PLNT • US72703H1014
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PLANET FITNESS INC - CL A (PLNT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | Keybanc | Initiate | Overweight |
| 2026-03-11 | Wells Fargo | Initiate | Overweight |
| 2026-02-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-29 | Macquarie | Maintains | Neutral -> Neutral |
| 2026-01-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-10 | Guggenheim | Initiate | Buy |
| 2025-11-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-14 | Stifel | Maintains | Buy -> Buy |
| 2025-11-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-11 | Macquarie | Maintains | Neutral -> Neutral |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-17 | UBS | Initiate | Buy |
| 2025-09-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-07 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-06-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-22 | Stifel | Upgrade | Hold -> Buy |
| 2025-05-13 | Macquarie | Maintains | Neutral -> Neutral |
| 2025-05-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-05-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.071B 14.36% | 1.182B 10.30% | 1.324B 12.06% | 1.475B 11.39% | 1.647B 11.66% | 1.805B 9.59% | 1.937B 7.31% | 2.095B 8.16% | |
| EBITDA YoY % growth | 422.387M 19.66% | 484.544M 14.72% | 550.462M 13.60% | 626.11M 13.74% | 711.84M 13.69% | 805.12M 13.10% | 878.63M 9.13% | 971.55M 10.58% | |
| EBIT YoY % growth | 272.974M 19.20% | 324.198M 18.77% | 394.677M 21.74% | 461.63M 16.96% | 531.53M 15.14% | 613.38M 15.40% | 683.71M 11.47% | 763.57M 11.68% | |
| Operating Margin | 25.48% | 27.44% | 29.81% | 31.30% | 32.27% | 33.98% | 35.30% | 36.45% | |
| EPS YoY % growth | 2.25 36.36% | 2.58 14.67% | 3.08 19.38% | 3.50 13.70% | 4.20 19.88% | 4.93 17.53% | 6.06 22.79% | 6.80 12.29% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.64 9.15% | 0.96 11.11% | 0.93 16.48% | 0.95 14.92% | 0.86 32.81% | 1.21 27.00% | 1.12 20.57% | 1.18 23.96% |
| Revenue Q2Q % growth | 305.28M 10.34% | 376.51M 10.45% | 376.42M 13.95% | 415.71M 10.49% | 364.1M 19.27% | 430.12M 14.24% | 418.97M 11.30% | 467.71M 12.51% |
| EBITDA Q2Q % growth | 130.47M 11.05% | 164.51M -8.15% | 162.93M -26.90% | 166.69M -36.33% | 157.31M 20.57% | 197.35M 19.96% | 186.49M 14.46% | 194.25M 16.53% |
| EBIT Q2Q % growth | 91.441M 15.45% | 125.73M 22.78% | 121.43M 13.41% | 123.68M 16.67% | 112.29M 22.80% | 149.21M 18.67% | 138.59M 14.13% | 147.87M 19.56% |
All data in USD
24 analysts have analysed PLNT and the average price target is 132.48 USD. This implies a price increase of 79.51% is expected in the next year compared to the current price of 73.8.
PLANET FITNESS INC - CL A (PLNT) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of PLANET FITNESS INC - CL A (PLNT) is 0.64 USD and the consensus revenue estimate is 305.28M USD.
The consensus rating for PLANET FITNESS INC - CL A (PLNT) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.